EVALUATING RISK FACTORS AND OUTCOMES OF FUNGAL INFECTIONS IN PREGNANCY: A PROSPECTIVE ANALYSIS
Main Article Content
Abstract
Abstract
Fungal infections, particularly vulvovaginal candidiasis (VVC), are frequent during pregnancy due to physiological changes like increased estrogen and immunosuppression. This prospective study examines the risk factors contributing to fungal infections in pregnancy and evaluates maternal and neonatal outcomes. A cohort of 300 pregnant women was followed, and the prevalence of fungal infections, key risk factors, and outcomes were analyzed. The study found that 18.4% of participants had fungal infections, primarily caused by Candida albicans, with elevated estrogen, previous VVC history, and diabetes as major contributing factors. In untreated cases, complications such as preterm delivery, low birth weight, and neonatal intensive care unit (NICU) admissions were observed. Early diagnosis and appropriate treatment significantly reduced adverse outcomes. This research highlights the importance of timely interventions and comprehensive patient education in reducing the impact of fungal infections during pregnancy.